Big News On Aspirin For Breast Cancer Survivors

by LaVonne on 19/02/10 at 3:04 am

There’s important news this week on the breast cancer front.

A study published by The Journal of Clinical Oncology suggests that regular, low-dose aspirin use reduces the risk of recurrence and death from breast cancer among women who’ve had stage I, II or III (non-metastatic) disease.

This is a remarkable report for three reasons:

1. The results are simple and significant. The study supports that among women who’ve had breast cancer, regular aspirin use more than halves the risk of death from cancer and greatly reduces the risk of recurrence.

2. The findings matter to millions of women who are living after breast cancer, today.

3. Aspirin is widely available, without patent restriction, and costs around $5 for 100 tablets.

Healthbuzz